Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 7, 2013, Pages 1050-1057

  Barker, Rachel ^a   Wellington, Dannielle ^a   Esiri, Margaret M ^b   Love, Seth ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

amyloid angiopathy; brain ischemia; cerebrovascular disease; dementia; white matter

Indexed keywords

MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; PARAFFIN; PROTEOLIPID PROTEIN;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN HOMOGENATE; BRAIN ISCHEMIA; BRAIN LEVEL; BRAIN TISSUE; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; SMALL VESSEL DISEASE; VASCULAR AMYLOIDOSIS; VASCULAR DISEASE; WHITE MATTER INJURY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOPSY; BRAIN ISCHEMIA; COHORT STUDIES; DEMENTIA, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; MIDDLE AGED; MYELIN BASIC PROTEIN; MYELIN PROTEOLIPID PROTEIN; MYELIN-ASSOCIATED GLYCOPROTEIN; PARIETAL LOBE; POSTMORTEM CHANGES; PROTEIN STABILITY; SEVERITY OF ILLNESS INDEX;

EID: 84880328751     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.46     Document Type: Article

References (35)

1. Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000; 21: 321-330
2. Meyer JS, Rauch GM, Rauch RA, Haque A, Crawford K. Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia. Ann NY Acad Sci 2000; 903: 411-423
3. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005; 64: 277-281
4. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 2005; 65: 545-551
5. Skoog I, Nilsson L, Persson G, Lernfelt B, Landahl S, Palmertz B et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141-1145
6. Li L, Zhang X, Yang D, Luo G, Chen S, Le W. Hypoxia increases Aβ generation by altering β-And γ-cleavage of APP. Neurobiol Aging 2009; 30: 1091-1098
7. Sun X, He G, Qing H, Zhou W, Dobie F, Cai F et al. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci USA 2006; 103: 18727-18732
8. Nalivaevaa NN, Fisk L, Kochkina EG, Plesneva SA, Zhuravin IA, Babusikova EVA et al. Effect of hypoxia/ischemia and hypoxic preconditioning/reperfusion on expression of some amyloid-degrading enzymes. Ann NY Acad Sci 2004; 1035: 21-33
9. Niwa K, Kazama K, Younkin L, Younkin SG, Carlson GA, Iadecola C. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol 2002; 283: H315-H323
10. Niwa K, Porter VA, Kazama K, Cornfield D, Carlson GA, Iadecola C. Aβ-peptides enhance vasoconstriction in cerebral circulation. Am J Physiol Heart Circ Physiol 2001; 281: H2417-H2424
11. Niwa K, Younkin L, Ebeling C, Turner SK, Westaway D, Younkin S et al. Aβ1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci USA 2000; 97: 9735-9740
12. Palmer JC, Barker R, Kehoe PG, Love S. Endothelin-1 is elevated in Alzheimer's disease and upregulated by amyloid-beta. J Alzheimers Dis 2012; 29: 853-861
13. Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, part XV. Neurology 1996; 46: 1592-1596
14. Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 1995; 52: 702-708
15. Johnson ES, Ludwin SK. Evidence for a 'dying-back' gliopathy in demyelinating disease. Ann Neurol 1981; 9: 301-305
16. Sternberger NH, Quarles RH, Itoyama Y, Webster HD. Myelin-Associated glycoprotein demonstrated immunocytochemically in myelin and myelin-forming cells of developing rat. Proc Natl Acad Sci USA 1979; 76: 1510-1514
17. Trapp BD, Andrews SB, Cootauco C, Quarles R. The myelin-Associated glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively myelinating oligodendrocytes. J Cell Biol 1989; 109: 2417-2426
18. Omlin FX, Webster HD, Palkovits CG, Cohen SR. Immunocytochemical localization of basic protein in major dense line regions of central and peripheral myelin. J Cell Biol 1982; 95: 242-248
19. Hudson LD, Friedrich VL, Behar T, Dubois-Dalcq M, Lazzarini RA. The initial events in myelin synthesis: Orientation of proteolipid protein in the plasma membrane of cultured oligodendrocytes. J Cell Biol 1989; 109: 717-727
20. Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Bruck W et al. Preferential loss of myelin-Associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol 2003; 62: 25-33
21. Itoyama Y, Sterhberger NH, Webster HD, Quarles RH, Cohen SR, Richardson EP. Immunocytochemical observations on the distribution of myelin-Associated glycoprotein and myelin basic protein in multiple sclerosis lesions. Ann Neurol 1980; 7: 167-177
22. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707-717
23. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486
24. The National Institute on Aging. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997; 18: S1-S2.
25. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R et al. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996; 47: 190-196
26. Chalmers K, Wilcock GK, Love S. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. Neuropathol Appl Neurobiol 2003; 29: 231-238
27. Smallwood A, Oulha A, Joachim C, Christie S, Sloan C, Smith AD et al. Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: A pathological study in the OPTIMA cohort. Neuropathol Appl Neurobiol 2011; 38: 337-343
28. Kövari E, Gold G, Herrmann FR, Canuto A, Hof PR, Michel J-P et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 2004; 35: 410-414
29. Love S. Contribution of cerebral amyloid angiopathy to Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004; 75: 1-4.
30. Cadavid D, Mena H, Koeller K, Frommelt RA. Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol 2000; 59: 768-773
31. Gray F, Dubas F, Roullet E, Escourolle R. Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 1985; 18: 54-59
32. Hollander D, Strich SJ. Atypical Alzheimer's disease with congophilic angiopathy presenting with dementia of acute onset. In: Wolstenholme GEW, O'Connor M (eds) Ciba Foundation Symposium -Alzheimer's Disease and Related Conditions. John Wiley & Sons: Chichester, UK, 1970, pp 105-135
33. Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis CE, Barber R et al. White matter lesions in an unselected cohort of the elderly. Stroke 2006; 37: 1391-1398
34. Gurol ME, Irizarry MC, Smith EE, Raju S, Diaz-Arrastia R, Bottiglieri T et al. Plasma b-Amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 2006; 66: 23-29
35. Miners S, Ashby E, Baig S, Harrison R, Tayler H, Speedy E et al. Angiotensinconverting enzyme levels and activity in Alzheimer's disease: Differences in brain and CSF ACE and association with ACE1 genotypes. Am J Transl Res 2009; 1: 163-177